Cervical Cancer symptoms are the clinical manifestations produced by malignant disease of the cervix, the lower part of the uterus connecting to the vagina. A defining feature of Cervical Cancer is that early and precancerous stages are typically asymptomatic, which is why screening rather than symptom recognition i…
Cervical Cancer symptoms are the clinical manifestations produced by malignant disease of the cervix, the lower part of the uterus connecting to the vagina. A defining feature of Cervical Cancer is that early and precancerous stages are typically asymptomatic, which is why screening rather than symptom recognition is central to early detection. As disease progresses, the most common presenting symptoms include abnormal vaginal bleeding, such as bleeding between periods, after intercourse, or after menopause, along with abnormal or persistent vaginal discharge, pelvic pain, and pain during intercourse. More advanced disease, in which the tumor invades adjacent structures, may cause additional symptoms such as pelvic or back pain, urinary or bowel complaints, and leg swelling. Because these features can resemble those of benign gynecological conditions, they require clinical evaluation and confirmation through cytology, HPV testing, colposcopy, and biopsy. The underlying disease is driven predominantly by persistent infection with high-risk human papillomavirus, and the largely silent early course underscores the importance of regular screening among women across diverse settings, where uptake varies considerably. Recognizing warning symptoms and ensuring timely assessment supports earlier diagnosis and more effective treatment. Research in this area addresses symptom presentation, the role of HPV in carcinogenesis, and the screening behaviors and access factors that determine whether Cervical Cancer is detected before it becomes advanced.
7 peer-reviewed articles, ranked by relevance. Each links to its DOI.